durapatite has been researched along with risedronic acid in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 15 (83.33) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, R; Coxon, F; Dunford, JE; Ebetino, FH; Kashemirov, BA; Marma, MS; McKenna, CE; Russell, RG; Stewart, C; Triffitt, JT; Xia, Z | 1 |
| Ito, M; Mihara, M; Miyabe, S; Nakano, T; Shiraishi, A; Umakoshi, Y | 1 |
| Barnett, BL; Dunford, JE; Ebetino, FH; Lawson, MA; Locklin, RM; Phipps, RJ; Russell, RG; Triffitt, JT; Xia, Z | 1 |
| Henry, C; Jahnke, W | 1 |
| Bhat, MR; Khajuria, DK; Mahapatra, DR; Mariappan, L; Rao, RR; Razdan, R; Sahana, H; Suresh, S | 1 |
| Ahmad, FJ; Gupta, S; Kalam, A; Manglani, K; Rawat, P; Talegaonkar, S; Vohora, D | 1 |
| Disha, C; Khajuria, DK; Mahapatra, DR; Razdan, R; Vasireddi, R | 1 |
| Ahmad, FJ; Ahmad, I; Gupta, S; Pandey, S; Rawat, P; Talegaonkar, S; Thomas, SC; Vohora, D | 1 |
| Jampílek, J; Jezierska, K; Pietrzyńska, M; Tomczak, R; Voelkel, A | 1 |
| Czerwiński, M; Pietrzyńska, M; Voelkel, A | 1 |
| Ginalska, G; Kolmas, J; Oledzka, E; Pajchel, L; Pajor, K; Przekora, A; Sobczak, M | 1 |
| Bigi, A; Boanini, E; Brouillet, F; Combes, C; Forte, L; Gazzano, M; Marsan, O; Sarda, S | 1 |
| Khajuria, DK; Razdan, R; Zahra, SF | 1 |
| Belafsky, PC; Cates, DJ; Nativ-Zeltzer, N; Randall, DR; Tinling, SP | 1 |
| Abdelkhalek, AA; Morsi, NM; Nabil Shamma, R; Osama Eladawy, N | 1 |
| Abdelkhalek, AA; Eladawy, NO; Morsi, NM; Shamma, RN | 1 |
| Keskes, H; Lefeuvre, B; Mosbahi, S; Oudadesse, H; Roiland, C; Slimani, L | 1 |
| Chen, L; Li, W; Ni, B; Sun, J; Tao, Y; Wang, J | 1 |
18 other study(ies) available for durapatite and risedronic acid
| Article | Year |
|---|---|
Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.
Topics: Alkyl and Aryl Transferases; Animals; Bone Density Conservation Agents; Cell Line; Cell Proliferation; Cell Survival; Chromatography, Liquid; Diphosphonates; Durapatite; Etidronic Acid; Geranyltranstransferase; Mice; Organophosphonates; Propionates; Protein Prenylation; Pyridines; Risedronic Acid; Structure-Activity Relationship | 2007 |
The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis.
Topics: Animals; Biomarkers; Biomechanical Phenomena; Bone Density; Bone Density Conservation Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Durapatite; Etidronic Acid; Female; Femur; Humans; Hydroxycholecalciferols; Lumbar Vertebrae; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Wistar; Risedronic Acid; Stress, Mechanical; Treatment Outcome; Weight-Bearing; X-Ray Diffraction; X-Ray Microtomography | 2009 |
Differences between bisphosphonates in binding affinities for hydroxyapatite.
Topics: Bone Density Conservation Agents; Chromatography, Liquid; Diphosphonates; Durapatite; Etidronic Acid; Imidazoles; Risedronic Acid; Spectrophotometry, Ultraviolet; Zoledronic Acid | 2010 |
An in vitro assay to measure targeted drug delivery to bone mineral.
Topics: Alendronate; Anabolic Agents; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Drug Delivery Systems; Durapatite; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Nuclear Magnetic Resonance, Biomolecular; Pamidronate; Risedronic Acid; Zoledronic Acid | 2010 |
Improvement in bone properties by using risedronate adsorbed hydroxyapatite novel nanoparticle based formulation in a rat model of osteoporosis.
Topics: Adsorption; Animals; Biomechanical Phenomena; Bone and Bones; Bone Density; Chemistry, Pharmaceutical; Disease Models, Animal; Durapatite; Etidronic Acid; Femur; Nanoparticles; Osteoporosis; Porosity; Rats; Rats, Wistar; Risedronic Acid; Spectroscopy, Fourier Transform Infrared; Tibia; X-Ray Diffraction | 2013 |
Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation.
Topics: Animals; Bone and Bones; Chemistry, Pharmaceutical; Dexamethasone; Drug Carriers; Durapatite; Lactic Acid; Male; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Wistar; Risedronic Acid; Spectroscopy, Fourier Transform Infrared; Tablets | 2015 |
Risedronate/zinc-hydroxyapatite based nanomedicine for osteoporosis.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Density Conservation Agents; Calcium; Creatinine; Disease Models, Animal; Drug Carriers; Durapatite; Nanomedicine; Nanoparticles; Osteoporosis; Rats; Rats, Wistar; Risedronic Acid; Tartrate-Resistant Acid Phosphatase; X-Ray Diffraction; X-Ray Microtomography; Zinc | 2016 |
Revisiting bone targeting potential of novel hydroxyapatite based surface modified PLGA nanoparticles of risedronate: Pharmacokinetic and biochemical assessment.
Topics: Animals; Biological Availability; Bone and Bones; Bone Density Conservation Agents; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Durapatite; Male; Mice; Nanoparticles; Osteoblasts; Osteoporosis; Polyesters; Polyethylene Glycols; Rats; Rats, Wistar; Risedronic Acid | 2016 |
Polymer-ceramic Monolithic In-Needle Extraction (MINE) device: Preparation and examination of drug affinity.
Topics: Animals; Body Fluids; Ceramics; Durapatite; Humans; Needles; Polymers; Risedronic Acid | 2016 |
Poly(vinyl alcohol)/hydroxyapatite Monolithic In-Needle Extraction (MINE) device: Preparation and examination of drug affinity.
Topics: Adsorption; Body Fluids; Bone Density Conservation Agents; Durapatite; Needles; Polyvinyl Alcohol; Risedronic Acid | 2017 |
Fabrication and physicochemical characterization of porous composite microgranules with selenium oxyanions and risedronate sodium for potential applications in bone tumors.
Topics: Alginates; Anions; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Drug Carriers; Durapatite; Glucuronic Acid; Hexuronic Acids; Humans; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Nanoparticles; Osteosarcoma; Porosity; Powders; Risedronic Acid; Selenium; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2017 |
Hydroxyapatite functionalization to trigger adsorption and release of risedronate.
Topics: Adsorption; Animals; Bone and Bones; Bone Density Conservation Agents; Bone Resorption; Delayed-Action Preparations; Drug Liberation; Durapatite; Kinetics; Microscopy, Electron, Transmission; Polyethyleneimine; Risedronic Acid; Thermodynamics; X-Ray Diffraction | 2017 |
Effect of locally administered novel biodegradable chitosan based risedronate/zinc-hydroxyapatite intra-pocket dental film on alveolar bone density in rat model of periodontitis.
Topics: Alveolar Bone Loss; Animals; Bone Density; Bone Density Conservation Agents; Chitosan; Drug Carriers; Drug Liberation; Durapatite; Osteocalcin; Osteoclasts; Periodontitis; Rats, Wistar; Risedronic Acid; Tartrate-Resistant Acid Phosphatase; Zinc | 2018 |
Decreased intramuscular calcium hydroxyapatite implant resorption in a murine model of osteoporosis.
Topics: Animals; Disease Models, Animal; Drug Implants; Durapatite; Female; Injections; Muscle, Skeletal; Osteoporosis; Ovariectomy; Prospective Studies; Rats; Rats, Sprague-Dawley; Risedronic Acid; Thigh | 2018 |
Bioactive injectable triple acting thermosensitive hydrogel enriched with nano-hydroxyapatite for bone regeneration: in-vitro characterization, Saos-2 cell line cell viability and osteogenic markers evaluation.
Topics: Bone Cements; Bone Density Conservation Agents; Bone Regeneration; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Drug Liberation; Durapatite; Glycerophosphates; Humans; Hydrogels; Materials Testing; Nanoparticles; Osteogenesis; Porosity; Risedronic Acid; Temperature; Tissue Engineering | 2019 |
Risedronate-Loaded Macroporous Gel Foam Enriched with Nanohydroxyapatite: Preparation, Characterization, and Osteogenic Activity Evaluation Using Saos-2 Cells.
Topics: Alginates; Bone Density Conservation Agents; Cell Line, Tumor; Drug Liberation; Durapatite; Humans; Methylcellulose; Nanostructures; Osteogenesis; Poloxamer; Porosity; Risedronic Acid | 2019 |
Risedronate Effects on the In Vivo Bioactive Glass Behavior: Nuclear Magnetic Resonance and Histopathological Studies.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Durapatite; Female; Glass; Magnetic Resonance Spectroscopy; Osteoporosis; Rats; Rats, Wistar; Risedronic Acid | 2019 |
Hydroxyapatite surface-functionalized monolithic column for selective in-tube solid phase microextraction of zoleronic acid and risedronic acid.
Topics: Chromatography, High Pressure Liquid; Durapatite; Hydroxyapatites; Limit of Detection; Reproducibility of Results; Risedronic Acid; Solid Phase Microextraction | 2021 |